Excellent strength, visibility, and deliverability to the renal arteries.
74.3% of patients had a reduction in systolic blood pressure at 3 years1
Data on file at Abbott.
MAT-2405568 V1.0
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
MAT-2105201 v1.0